#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    White matter lesion Peritoneal mesothelioma malignant Extranodal marginal zone B-cell lymphoma (MALT type) Staphylococcal infection Cutaneous T-cell lymphoma stage II Angiosarcoma metastatic Inclusion body myositis Vernal keratoconjunctivitis Neonatal alloimmune thrombocytopenia Immune-mediated enterocolitis Thalassaemia alpha Angiosarcoma non-metastatic Medulloblastoma Neovascular age-related macular degeneration Oropharyngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Factor VIII deficiency Idiopathic pulmonary fibrosis – Basic Information Angiosarcoma Myxofibrosarcoma – Life with Disease Niemann-Pick disease Glomerulonephritis rapidly progressive – Trials in Disease Niemann-Pick disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    POLYSORBATE 80 Epacadostat Tegoprubart Df6002 ADS-019 10-1074-Ls Lidocaine Sodium Hydrogen Carbonate Bempedoic Acid Brimonidine Tartrate Vedolizumab Vincristine Regn7075 Fexofenadine Hydrochloride BRENSOCATIB Gadobenate Dimeglumine Tamoxifen Sugammadex Lovastatin Germanium (68Ge) Chloride More therapies…

    Learn about Your Condition

    Vertigo Mitral valve incompetence Ovarian epithelial cancer Intellectual disability Malabsorption Pulmonary tuberculosis Chorea Malignant peritoneal neoplasm Undifferentiated sarcoma Hereditary ataxia Lung cancer metastatic Myelodysplastic syndrome Immune-mediated renal disorder Osteogenesis imperfecta Angiosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Retinoblastoma Treatment: Evaluating the Effectiveness of Topotecan, Vincristine Sulfate, and Etoposide in Patients Eligible for Conservative Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Topotecan
    • Carboplatin
    France
  • Long-Term Safety Study of ACP-204 for Adults with Alzheimer’s Disease Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain
  • Study on the Safety and Effectiveness of Linvoseltamab, Sarilumab, and Dexamethasone in Adults with Relapsed or Refractory AL Amyloidosis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Primary amyloidosis
    Investigated Drugs:
    • Dexamethasone
    • Dexamethasone Sodium Phosphate
    • Diphenhydramine Hydrochloride
    Greece Spain
  • Evaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    Investigated Drugs:
    • Bevacizumab
    • Prednisolone
    • Sodium Chloride
    France
  • Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Epstein-Barr virus infection reactivation
    Investigated Drugs:
    • Deoxyribonucleic Acid
    • Interferon Alfa
    • Interferon Gamma
    Belgium
  • Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Eletriptan
    Portugal Spain
Previous Page
1 … 496 497 498 499 500 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!